Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma

被引:37
作者
Langdon, JA
Lamont, JM
Scott, DK
Dyer, S
Prebble, E
Bown, N
Grundy, RG
Ellison, DW
Clifford, SC
机构
[1] Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Univ Birmingham, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England
[4] Birminghams Womens Hosp, Reg Genet Lab, Birmingham, W Midlands, England
关键词
D O I
10.1002/gcc.20262
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Detailed analysis of mechanisms of genetic loss for specific tumor suppressor genes (TSGs; e.g., RBI, APC and NFI) indicates that TSG inactivation can occur by allelic loss of heterozygosity (LOH), without any alteration in DNA copy number However, the role and prevalence of such events in the pathogenesis of specific malignancies remains to be established on a genomewide basis. We undertook a detailed molecular assessment of chromosomal defects in a panel of nine cell lines derived from primary medulloblastomas, the most common malignant brain tumors of childhood, by parallel genome-wide assessment of LOH (allelotyping) and copy number aberrations (comparative genomic hybridization and fluorescence in situ hybridization). The majority of genetic losses observed were detected by both copy number and LOH methods, indicating they arise through the physical deletion of chromosomal material. However, a significant proportion of losses (17/42, 40%) represented regions of allelic LOH without any associated copy number reduction; these events involved both whole chromosomes (10/17) and sub-chromosomal regions (7/17). Using this approach, we identified medulloblastorna-characteristic alterations, e.g., isochromosome for 17q, MYC amplification and losses on chromosomes 10, 11, and 16, alongside novel regions of genetic loss (e.g., 10q21.1-26.3, 11q24.1-qter). This detailed genetic characterization of the majority of medulloblastorna cell lines provides important precedent for the widespread involvement of copy number-neutral genetic losses in medulloblastorna and demonstrates that combined assessment of copy number aberrations and LOH will be necessary to accurately determine the contribution of chromosomal defects to tumor development. This article contains Supplementary Material available at http://www.interscience.wiIey.com/jpages/1045-2257/suppmat. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:47 / 60
页数:14
相关论文
共 39 条
[1]   Genomic microarrays in human genetic disease and cancer [J].
Albertson, DG ;
Pinkel, D .
HUMAN MOLECULAR GENETICS, 2003, 12 :R145-R152
[2]   MICROSATELLITE ANALYSIS OF LOSS OF HETEROZYGOSITY ON CHROMOSOMES 9Q, 11P AND 17P IN MEDULLOBLASTOMAS [J].
ALBRECHT, S ;
VONDEIMLING, A ;
PIETSCH, T ;
GIANGASPERO, F ;
BRANDNER, S ;
KLEIHUES, P ;
WIESTLER, OD .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1994, 20 (01) :74-81
[3]  
Aldosari N, 2002, NEURO-ONCOLOGY, V4, P75, DOI 10.1093/neuonc/4.2.75
[4]   Comparative genome hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children [J].
Avet-Loiseau, H ;
Vénuat, AM ;
Terrier-Lacombe, MJ ;
Lellouch-Tubiana, A ;
Zerah, M ;
Vassal, G .
BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) :1843-1847
[5]   High-resolution analysis of DNA copy number using oligonucleotide microarrays [J].
Bignell, GR ;
Huang, J ;
Greshock, J ;
Watt, S ;
Butler, A ;
West, S ;
Grigorova, M ;
Jones, KW ;
Wei, W ;
Stratton, MR ;
Futreal, PA ;
Weber, B ;
Shapero, MH ;
Wooster, R .
GENOME RESEARCH, 2004, 14 (02) :287-295
[6]  
Blaeker H, 1996, GENE CHROMOSOME CANC, V15, P54, DOI 10.1002/(SICI)1098-2264(199601)15:1<54::AID-GCC8>3.0.CO
[7]  
2-3
[8]   EXPRESSION OF RECESSIVE ALLELES BY CHROMOSOMAL MECHANISMS IN RETINOBLASTOMA [J].
CAVENEE, WK ;
DRYJA, TP ;
PHILLIPS, RA ;
BENEDICT, WF ;
GODBOUT, R ;
GALLIE, BL ;
MURPHREE, AL ;
STRONG, LC ;
WHITE, RL .
NATURE, 1983, 305 (5937) :779-784
[9]  
Chung DC, 1998, CANCER RES, V58, P3706
[10]  
Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO